Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation
Status unconfirmed · Phase 1
Conditions studied: Stroke
In brief
The goal of this clinical trial is to investigate upper-extremity vibrotactile stimulation with wearables in stroke patients. The main questions it aims to answer are: Are the wearables well-tolerated by patients? Does the vibrotactile stimulation help regain arm function? Participants will wear vibrotactile stimulation gloves and shirts for 5 hours daily during their stay at the rehabilitation unit, in addition to conventional therapy. Researchers will compare the treatment group (vibrotactile stimulation wearables) with a control group (conventional therapy only) to see the effects of the vibrotactile stimulation.
Key facts
- Study ID
- NCT06244719
- Run by
- University of Colorado, Denver
- People needed
- 24
- Starts
- 2024-02-02
- Expected to finish
- 2025-02-02
- Last updated by the study team
- 2024-04-11
Who can join
Age: 50 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Inpatients at rehabilitation units
- Unilateral left or right sided ischemic stroke within the previous 2 weeks
- Have Upper-Extremity Fugl-Meyer scores between 6 and 58
- Have at least 20 degrees of active shoulder elevation and elbow flexion
- Expected to stay 1-3 weeks in the rehabilitation unit
You may not qualify if…
- Under anti-spasticity therapy
- Patients that are dependent on pacemakers
- Patients that have defibrillators
- Have lymphedema or AV fistula for dialysis on an arm
Where it is running
- UCHealth Rehabilitation Unit — Aurora, Colorado, United States (enrolling)
- Broomfield Hospital — Broomfield, Colorado, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.